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Summary: Educational attainment (EA) is strongly influenced by social and other 6 
environmental factors, but genetic factors are also estimated to account for at least 20% of the 7 
variation across individuals1. We report the results of a genome-wide association study 8 
(GWAS) for EA that extends our earlier discovery sample1,2 of 101,069 individuals to 293,723 9 
individuals, and a replication in an independent sample of 111,349 individuals from the UK 10 
Biobank. We now identify 74 genome-wide significant loci associated with number of years of 11 
schooling completed. Single-nucleotide polymorphisms (SNPs) associated with educational 12 
attainment are disproportionately found in genomic regions regulating gene expression in the 13 
fetal brain. Candidate genes are preferentially expressed in neural tissue, especially during the 14 
prenatal period, and enriched for biological pathways involved in neural development. Our 15 
findings demonstrate that, even for a behavioral phenotype that is mostly environmentally 16 
determined, a well-powered GWAS identifies replicable associated genetic variants that 17 
suggest biologically relevant pathways. Because EA is measured in large numbers of 18 
individuals, it will continue to be useful as a proxy phenotype in efforts to characterize the 19 
genetic influences of related phenotypes, including cognition and neuropsychiatric disease. 20 
 21 
Main Text: 22 
We study educational attainment (EA), which is measured in all main analyses as the number 23 
of years of schooling completed (EduYears, N = 293,723, mean = 14.33, SD = 3.61; 24 
Supplementary Information sections 1.1-1.2). All genome-wide association studies (GWAS) 25 
were performed at the cohort level in samples restricted to individuals of European descent 26 
whose EA was assessed at or above age 30. A uniform set of quality-control (QC) procedures 27 
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was applied to the cohort-level summary statistics. In our GWAS meta-analysis of ~9.3M SNPs 1 
from the 1000 Genomes Project, we used sample-size weighting and applied a single round of 2 
genomic control at the cohort level. 3 
Our meta-analysis identified 74 approximately independent genome-wide significant loci. For 4 
each locus, we define the “lead SNP” as the SNP in the genomic region that has the smallest 5 
P-value (Supplementary Information section 1.6.1). Fig. 1 shows a Manhattan plot with the 6 
lead SNPs highlighted. The three SNPs that reached genome-wide significance in the discovery 7 
stage of our previous GWAS meta-analysis of EA1 are also highlighted. The quantile-quantile 8 
(Q-Q) plot of the meta-analysis (Extended Data Fig. 1) exhibits inflation (λGC = 1.28), as 9 
expected under polygenicity3. 10 
Extended Data Fig. 2 shows the estimated effect sizes of the lead SNPs. The estimates range 11 
from 0.014 to 0.048 standard deviations per allele (2.7 to 9.0 weeks of schooling), with 12 
incremental R2 in the range 0.01% to 0.035%.  13 
To quantify the amount of population stratification in the GWAS estimates that remains even 14 
after the stringent controls used by the cohorts (Supplementary Information section 1.4), we 15 
used LD Score regression4. The regression results indicate that ~8% of the observed inflation 16 
in the mean χ2 is due to bias rather than polygenic signal (Extended Data Fig. 3a),  suggesting 17 
that stratification effects are small in magnitude. We also found evidence that the genetic 18 
association signals taken as a whole replicate reliably in several within-family analyses 19 
(Supplementary Information section 2 and Extended Data Fig. 3b). 20 
To further test the robustness of our findings, we examined the within-sample and out-of-21 
sample   replicability   of   SNPs   reaching   genome-wide   significance   (Supplementary 22 
Information sections 1.7-1.8). We found that SNPs identified in the previous EA meta-analysis 23 
replicated in the new cohorts included here, and conversely, that SNPs reaching genome-wide 24 
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significance in the new cohorts replicated in the old cohorts. For the out-of-sample replication 1 
analyses of our 74 lead SNPs, we used the interim release of the U.K. Biobank 5 (UKB) (N = 2 
111,349). As shown in Extended Data Fig. 4, 72 out of the 74 lead SNPs have a consistent sign 3 
(P = 1.47×10−19), 52 are significant at the 5% level (P = 2.68×10−50), and 7 reach genome-wide 4 
significance in the U.K. Biobank dataset (P = 1.41×10−42). For comparison, the corresponding 5 
expected numbers, assuming each SNP’s true effect size is its estimated effect adjusted for the 6 
winner’s curse, are 71.4, 40.3, and 0.6. (Supplementary Information section 1.8.2). We also 7 
find out-of-sample replicability of our overall GWAS results: the genetic correlation between 8 
EduYears in our meta-analysis sample and in the UKB data is 0.95 (s.e. = 0.021; Supplementary 9 
Table 1.14). 10 
It is known that EA, cognitive performance, and many neuropsychiatric phenotypes are 11 
phenotypically correlated, and several studies of twins find that the phenotypic correlations 12 
partly  reflect  genetic  overlap6–8  (Supplementary  Information  section  3.3.4).  Here, we 13 
investigate genetic correlation using our GWAS results for EduYears and published GWAS 14 
results for 14 other phenotypes, using bivariate Linkage-Disequilibrium (LD) Score 15 
regression9. First, we estimated genetic correlations with EduYears. As shown in Fig. 2, on 16 
average, alleles associated with greater EA are also associated with increased cognitive 17 
performance (P = 9.9×10-50) and intracranial volume (P = 1.2×10-6), increased risk of bipolar 18 
disorder (P = 7×10-13), decreased risk of Alzheimer’s (P = 4×10-4), and lower neuroticism (P 19 
= 2.8×10-8). We also found positive, statistically significant, but very small, genetic 20 
correlations with height (P = 5.2×10-15) and risk of schizophrenia (P = 3.2×10-4). 21 
Second, we examined whether our 74 lead SNPs are jointly associated with each phenotype 22 
(Extended Data Fig. 5 and Supplementary Information section 3.3.1). We reject the null 23 
hypothesis of no enrichment at P < 0.05 for 10 of the 14 phenotypes (all the exceptions are 24 
subcortical brain structures).  25 
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Third, for each phenotype, we tested (in the published GWAS results) each of our 74 lead SNPs 1 
or proxy for association at a significance threshold of 0.05/74. We found a total of 25 SNPs 2 
meeting this threshold for any of these phenotypes (but only one reaching genome-wide 3 
significance). While these results provide suggestive evidence that some of these SNPs may be 4 
associated with other phenotypes, further testing of these associations in independent cohorts 5 
is required (Supplementary Tables 3.2-3.4, Extended Data Fig. 6).  6 
To consider potential biological pathways, we first tested whether SNPs in particular regions 7 
of the genome are implicated by our GWAS results. Unlike what has been  found for other 8 
phenotypes, SNPs in regions that are DNase I hypersensitive in the fetal brain are more likely 9 
to be associated with EduYears by a factor of ~5 (95% confidence interval 2.89–7.07; Extended 10 
Data Fig. 7). Moreover, the 15% of SNPs residing in regions associated with histones marked 11 
in the central nervous system (CNS) explain 44% of the heritable variation (Extended Data Fig. 12 
8a and Supplementary Table 4.4.2). This enrichment factor of ~3 for CNS (P = 2.48×10−16) is 13 
greater than that of any of the other nine tissue categories in this analysis. 14 
Given that our findings disproportionately implicate SNPs in regions regulating brain-specific 15 
gene expression, we examined whether genes located near EduYears-associated SNPs show 16 
elevated expression in neural tissue. We tested this hypothesis using data on mRNA transcript 17 
levels in the 37 adult tissues assayed by the Genotype-Tissue Expression Project (GTEx)10. 18 
Remarkably, the 13 GTEx tissues that are components of the CNS—and only those 13 19 
tissues—show significantly elevated expression levels of genes near EduYears-associated 20 
SNPs (FDR < 0.05; Extended Data Fig. 8b and Supplementary Table 4.5.2). 21 
To investigate possible functions of the candidate genes from the GWAS associated loci, we 22 
examined the extent of their overlap with groups of genes (“gene sets”) whose products are 23 
known or predicted to participate in a common biological process11. We found 283 gene sets 24 
significantly enriched by the candidate genes identified in our GWAS (FDR < 0.05; 25 
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Supplementary Table 4.5.1). To facilitate interpretation, we used a standard procedure11 to 1 
group the 283 gene sets into “clusters” defined by degree of gene overlap. The resulting 34 2 
clusters, shown in Fig. 3, paint a coherent picture, with many clusters corresponding to stages 3 
of neural development: the proliferation of neural progenitor cells and their specialization (the 4 
cluster npBAF complex), the migration of new neurons to the different layers of the cortex 5 
(forebrain development, abnormal cerebral cortex morphology), the projection of axons from 6 
neurons to their signaling targets (axonogenesis, signaling by Robo receptor), the sprouting of 7 
dendrites and their spines (dendrite,  dendritic  spine  organization),  and  neuronal  signaling  8 
and  synaptic  plasticity throughout  the  lifespan  (voltage-gated  calcium  channel  complex,  9 
synapse part,  synapse organization). 10 
Many of our results implicate candidate genes and biological pathways that are active during 11 
distinct stages of prenatal brain development. To directly examine how the expression levels 12 
of candidate genes identified in our GWAS vary over the course of development, we used gene 13 
expression data from the BrainSpan Developmental Transcriptome12. As shown in Extended 14 
Data Fig. 9, these candidate genes exhibit above-baseline expression in the brain throughout 15 
life but especially higher expression levels in the brain during prenatal development (1.36 times 16 
higher prenatally than postnatally, P = 6.02×10−8). 17 
A summary overview of some promising candidate genes for follow-up work is provided in 18 
Table 1.  19 
We constructed polygenic scores13 to assess the joint predictive power afforded by the GWAS 20 
results (Supplementary Information section 5.2). Across our two holdout samples, the mean 21 
predictive power of a polygenic score constructed from all measured SNPs is 3.2% (P = 22 
1.18×10−39; Supplementary Table 5.2 and Supplementary Information section 5). 23 
Studies of genetic analyses of behavioral phenotypes have been prone to misinterpretation, 24 
such as characterizing identified associated variants as “genes for education.” Such 25 
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characterization is not correct for many reasons: EA is primarily determined by environmental 1 
factors, the explanatory power of the  individual SNPs is small, the candidate genes may not be 2 
causal, and the genetic associations with EA are mediated by multiple intermediate 3 
phenotypes14. To illustrate this last point, we studied mediation of the association between the 4 
all-SNPs polygenic score and EduYears in two of our cohorts. We found that cognitive 5 
performance can statistically account for 23-42% of the association (P < 0.001) and the 6 
personality trait “openness to experience” for approximately 7% (P < 0.001; Supplementary 7 
Information section 6). 8 
 It would also be a mistake to infer from our findings that the genetic effects operate 9 
independently of environmental factors. Indeed, a recent meta-analysis of twin studies found 10 
that genetic influences on EA are heterogeneous across countries and birth cohorts15. We 11 
conducted exploratory analyses in the Swedish Twin Registry to illustrate how environmental 12 
factors may amplify or dampen the impact of genetic influences (Supplementary Information 13 
section 7). We found that the predictive power of the all-SNPs polygenic score is heterogeneous 14 
by birth cohort, with smaller explanatory power in younger cohorts (Extended Data Fig. 10; 15 
see also Supplementary Information section 7.4 for discussion of the contrast between these 16 
results and findings from a seminal twin study that estimated EA heritability by birth cohort16). 17 
 18 
Methods: All methods are described in the Supplementary Information. 19 
 20 
 21 
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Table 1 | Selected candidate genes implicated by bioinformatics analyses. Fifteen 1 
candidate genes implicated most consistently across various analyses. To assemble this list, 2 
each gene in a DEPICT-defined locus (Supplementary Information section 4.5) was assigned 3 
a score equal to the number of criteria it satisfies out of ten (see Supplementary Table 4.1 for 4 
details). The DEPICT prioritization P-value was used as the tiebreaker. “SNP”: the SNP in 5 
the gene’s locus with the lowest P-value in the EduYears meta-analysis. “Syndromic”: which, 6 
if any, of three neuropsychiatric disorders have been linked to de novo mutations in the gene 7 
(Supplementary Information section 4.6). “Top-ranking gene sets”: DEPICT reconstituted 8 
gene sets of which the gene is a top-20 member (Supplementary Table 4.5.1). The three most 9 
significant gene sets are shown if more than three are available. ID, intellectual disability; 10 
ASD, autism spectrum disorder; SCZ, schizophrenia. 11 
  12 
11 
  
 1 
Gene SNP Syndromic Score Top-ranking gene sets 
TBR1 rs4500960 ID, ASD 6 Developmental biology, decreased brain size, 
abnormal cerebral cortex morphology 
MEF2C rs7277187 ID, ASD 5 ErbB signaling pathway, abnormal sternum 
ossification, regulation of muscle cell 
differentiation 
ZSWIM6 rs61160187 – 5 Transcription factor binding, negative 
regulation of signal transduction, PI3K events 
in ErbB4 signaling 
BCL11A rs2457660 ASD 5 Dendritic spine organization, abnormal 
hippocampal mossy fiber morphology, 
SWI/SNF-type complex 
CELSR3 rs11712056 SCZ 5 Dendrite morphogenesis, dendrite 
development, abnormal hippocampal mossy 
fiber morphology 
MAPT rs192818565 ID 5 Dendrite morphogenesis, abnormal 
hippocampal mossy fiber morphology, 
abnormal axon guidance 
SBNO1 rs7306755 SCZ 5 Protein serine/threonine phosphatase complex 
NBAS rs12987662 – 5 – 
NBEA rs9544418 SCZ 4 Developmental biology, signaling by Robo 
receptor, dendritic shaft 
SMARCA2 rs1871109 ID 4 – 
MAP4 rs11712056 ASD 4 Developmental biology, signaling by Robo 
receptor, SWI-SNF-type complex 
LINC00461 rs10061788 – 4 Decreased brain size, abnormal cerebral cortex 
morphology, abnormal hippocampal mossy 
fiber morphology 
POU3F2 rs9320913 – 4 Dendrite morphogenesis, developmental 
biology, decreased brain size 
RAD54L2 rs11712056 SCZ 4 Decreased brain size, SWI/SNF-type complex, 
nBAF complex 
PLK2 rs2964197 – 4 Negative regulation of signal transduction, 
PI3K events in ErbB4 signaling 
  2 
12 
  
Authors: 1 
Aysu Okbay1,2,3,*, Jonathan P. Beauchamp4,*, Mark A. Fontana5,*, James J. Lee6,*, Tune H. 2 
Pers7,8,9,10,*, Cornelius A. Rietveld1,2,3,*, Patrick Turley4,*, Guo-Bo Chen11, Valur 3 
Emilsson12,13, S. Fleur W. Meddens14,3,15, Sven Oskarsson16, Joseph K. Pickrell17, Kevin 4 
Thom18, Pascal Timshel19,8, Ronald de Vlaming1,2,3, Abdel Abdellaoui20, Tarunveer S. 5 
Ahluwalia21,9 ,22, Jonas Bacelis23, Clemens Baumbach24,25, Gyda Bjornsdottir95, Johannes H. 6 
Brandsma26, Maria Pina Concas27, Jaime Derringer28, Nicholas A. Furlotte29, Tessel E. 7 
Galesloot30, Giorgia Girotto31, Richa Gupta32, Leanne M. Hall33,34, Sarah E. Harris35,36, Edith 8 
Hofer37,38, Momoko Horikoshi39,40, Jennifer E. Huffman41, Kadri Kaasik42, Ioanna P. 9 
Kalafati43, Robert Karlsson44, Augustine Kong95, Jari Lahti42,45, Sven J. van der Lee2, 10 
Christiaan de Leeuw14,46, Penelope A. Lind47, Karl-Oskar Lindgren16, Tian Liu48, Massimo 11 
Mangino49,50, Jonathan Marten41, Evelin Mihailov114, Michael B. Miller6, Peter J. van der 12 
Most51, Christopher Oldmeadow52,53, Antony Payton54,55, Natalia Pervjakova56,114, Wouter J. 13 
Peyrot57, Yong Qian58, Olli Raitakari59, Rico Rueedi60,61, Erika Salvi62, Börge Schmidt63, 14 
Katharina E. Schraut64, Jianxin Shi65, Albert V. Smith66,67, Raymond A. Poot26, Beate St 15 
Pourcain68,69, Alexander Teumer70, Gudmar Thorleifsson95, Niek Verweij71, Dragana 16 
Vuckovic31, Juergen Wellmann72, Harm-Jan Westra73,74,8, Jingyun Yang75,76, Wei Zhao77, 17 
Zhihong Zhu11, Behrooz Z. Alizadeh51,78, Najaf Amin2, Andrew Bakshi11, Sebastian E. 18 
Baumeister70,79, Ginevra Biino80, Klaus Bønnelykke21, Patricia A. Boyle75,81, Harry 19 
Campbell64, Francesco P. Cappuccio82, Gail Davies35,83, Jan-Emmanuel De Neve84, Panos 20 
Deloukas85,86, Ilja Demuth87,88, Jun Ding58, Peter Eibich89,90, Lewin Eisele63, Niina Eklund56, 21 
David M. Evans68,184, Jessica D. Faul91, Mary F. Feitosa92, Andreas J. Forstner93,94, Ilaria 22 
Gandin31, Bjarni Gunnarsson95, Bjarni V. Halldórsson95,96, Tamara B. Harris97, Andrew C. 23 
Heath98, Lynne J. Hocking99, Elizabeth G. Holliday52,53, Georg Homuth100, Michael A. 24 
Horan101, Jouke-Jan Hottenga20, Philip L. de Jager102,103,8, Peter K. Joshi64, Astanand 25 
13 
  
Jugessur104, Marika A. Kaakinen105, Mika Kähönen106,107, Stavroula Kanoni85, Liisa 1 
Keltigangas-Järvinen42, Lambertus A.L.M. Kiemeney30, Ivana Kolcic108, Seppo Koskinen56, 2 
Aldi T. Kraja92, Martin Kroh89, Zoltan Kutalik109,60,61, Antti Latvala32, Lenore J. Launer110, 3 
Maël P. Lebreton15,111, Douglas F. Levinson112, Paul Lichtenstein44, Peter Lichtner118, David 4 
C.M. Liewald35,83, LifeLines Cohort Study113, Anu Loukola32, Pamela A. Madden98, Reedik 5 
Mägi114, Tomi Mäki-Opas56, Riccardo E. Marioni35,115,11, Pedro Marques-Vidal116, Gerardus 6 
A. Meddens117, George McMahon68, Christa Meisinger25, Thomas Meitinger118, Yusplitri 7 
Milaneschi57, Lili Milani114, Grant W. Montgomery119, Ronny Myhre104, Christopher P. 8 
Nelson33,34, Dale R. Nyholt120,119, William E.R. Ollier54, Aarno Palotie121,8,122,123,124,125, 9 
Lavinia Paternoster68, Nancy L. Pedersen44, Katja E. Petrovic37, David J. Porteous36, Katri 10 
Räikkönen42,45, Susan M. Ring68, Antonietta Robino126, Olga Rostapshova4,127, Igor Rudan64, 11 
Aldo Rustichini128, Veikko Salomaa56, Alan R. Sanders129,130, Antti-Pekka Sarin124,131, Helena 12 
Schmidt132,37, Rodney J. Scott133,53, Blair H. Smith134, Jennifer A. Smith77, Jan A. 13 
Staessen135,136, Elisabeth Steinhagen-Thiessen87, Konstantin Strauch137,138, Antonio 14 
Terracciano139, Martin D. Tobin140, Sheila Ulivi126, Simona Vaccargiu27, Lydia Quaye49, 15 
Frank J.A. van Rooij2,141, Cristina Venturini49,50, Anna A.E. Vinkhuyzen11, Uwe Völker100, 16 
Henry Völzke70, Judith M. Vonk51, Diego Vozzi126, Johannes Waage21,22, Erin B. Ware77,142, 17 
Gonneke Willemsen20, John R. Attia52,53, David A. Bennett75,76, Klaus Berger71, Lars 18 
Bertram143,144, Hans Bisgaard21, Dorret I. Boomsma20, Ingrid B. Borecki92, Ute Bultmann145, 19 
Christopher F. Chabris146, Francesco Cucca147, Daniele Cusi62,148, Ian J. Deary35,83, George V. 20 
Dedoussis43, Cornelia M. van Duijn2, Johan G. Eriksson149,45, Barbara Franke150, Lude 21 
Franke155, Paolo Gasparini31,126,151, Pablo V. Gejman129,130, Christian Gieger24, Hans-Jörgen 22 
Grabe152,153, Jacob Gratten11, Patrick J.F. Groenen154, Vilmundur Gudnason12,67, Pim van der 23 
Harst71,155,156, Caroline Hayward41,157, David A. Hinds29, Wolfgang Hoffmann70, Elina 24 
Hyppönen158,159,160, William G. Iacono6, Bo Jacobsson23,104, Marjo-Riitta Järvelin161,162,163,164, 25 
14 
  
Karl-Heinz Jöckel63, Jaakko Kaprio32,124,56, Sharon L.R. Kardia77, Terho Lehtimäki165,166, 1 
Steven F. Lehrer167,168, Patrik K.E. Magnusson44, Nicholas G. Martin169, Matt McGue6, 2 
Andres Metspalu114,170, Neil Pendleton171,172, Brenda W.J.H. Penninx57, Markus Perola56,114, 3 
Nicola Pirastu31, Mario Pirastu27, Ozren Polasek173,64, Danielle Posthuma14,174, Christine 4 
Power160, Michael A. Province92, Nilesh J. Samani33,34, David Schlessinger58, Reinhold 5 
Schmidt37, Thorkild I.A. Sørensen175,9 ,68, Tim D. Spector49, Kari Stefansson95,67, Unnur 6 
Thorsteinsdottir95,67, A. Roy Thurik1,176,177,3, Nicholas J. Timpson68, Henning Tiemeier2,178,179, 7 
Joyce Y. Tung29, André G. Uitterlinden180,2, Veronique Vitart41, Peter Vollenweider116, David 8 
R. Weir91, James F. Wilson64,41, Alan F. Wright41, Dalton C. Conley181,182, Robert F. 9 
Krueger6, George Davey Smith68, Albert Hofman2, David I. Laibson4, Sarah E. Medland47, 10 
Michelle N. Meyer183, Jian Yang11,184, Magnus Johannesson185, Peter M. Visscher11,184,#, 11 
Tõnu Esko114,7,186,8,#, Philipp D. Koellinger14,15,3,#, David Cesarini18,187,#, Daniel J. 12 
Benjamin188,189,# 13 
 14 
* These authors contributed equally. 15 
# Designed and oversaw the study. 16 
1 Department of Applied Economics, Erasmus School of Economics, Erasmus University 
Rotterdam, 3062 PA, Rotterdam, The Netherlands 
2 Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The 
Netherlands 
3 Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam 3062 PA, The 
Netherlands 
4 Department of Economics, Harvard University, Cambridge, MA 02138, USA 
5 Department of Economics, University of Michigan, Ann Arbor, MI  48109-1220, USA 
                                                          
15 
  
                                                                                                                                                                                    
6 Department of Psychology, University of Minnesota Twin Cities, Minneapolis, MN 55455, 
USA 
7 Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston 
Children’s Hospital, Boston, MA 2116, USA 
8 Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 
Cambridge, MA 02142, USA 
9 The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic 
Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, 
2100, Denmark 
10 Statens Serum Institut, Department of Epidemiology Research, Copenhagen, DK 2300, 
Denmark 
11 Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia 
12 Icelandic Heart Association, Kopavogur, 201, Iceland 
13 Faculty of Pharmaceutical Sciences, University of Iceland, 107 Reykjavík, Iceland 
14 Department of Complex Trait Genetics, VU University, Center for Neurogenomics and 
Cognitive Research, Amsterdam, 1081 HV, The Netherlands 
15 Amsterdam Business School, University of Amsterdam, Amsterdam, 1018 TV, The 
Netherlands 
16 Department of Government, Uppsala University, Uppsala, 751 20, Sweden 
17 New York Genome Center, New York, NY 10013, USA 
18 Department of Economics, New York University, New York, NY 10012, USA 
19 Center for Biological Sequence Analysis, Department of Systems Biology, Technical 
University of Denmark Lyngby, 2800, Denmark 
20 Department of Biological Psychology, VU University Amsterdam, Amsterdam, 1081 BT, 
The Netherlands 
16 
  
                                                                                                                                                                                    
21 COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte 
Hospital, University of Copenhagen, Copenhagen, 2820, Denmark 
22 Steno Diabetes Center, Gentofte, 2820, Denmark 
23 Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska 
Academy, Gothenburg, SE 416 85, Sweden 
24 Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German 
Research Center for Environmental Health, Neuherberg, 85764, Germany 
25 Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for 
Environmental Health, Neuherberg, 85764, Germany 
26 Department of Cell Biology, Erasmus Medical Center Rotterdam, 3015 CN, The 
Netherlands 
27 Istituto di Ricerca Genetica e Biomedica U.O.S. di Sassari, National Research Council of 
Italy, Sassari, 07100, Italy 
28 Psychology, University of Illinois, IL 61820, Champaign, USA 
29 23andMe, Inc., Mountain View, CA 94041, USA 
30 Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, 
6500 HB, The Netherlands 
31 Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, 
34100, Italy 
32 Department of Public Health, University of Helsinki, Helsinki, FI-00014, Finland 
33 Department of Cardiovascular Sciences, University of Leicester, Leicester, LE3 9QP, UK 
34 NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, 
LE3 9QP, UK 
35 Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 
Edinburgh, EH8 9JZ, UK 
17 
  
                                                                                                                                                                                    
36 Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular 
Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK 
37 Department of Neurology, General Hospital and Medical University Graz, Graz, 8036, 
Austria 
38 Institute for Medical Informatics, Statistics and Documentation, General Hospital and 
Medical University Graz, Graz, 8036, Austria 
39 Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, 
OX3 7LE, UK 
40 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK 
41 MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of 
Edinburgh, Edinburgh, EH4 2XU, UK 
42 Institute of Behavioural Sciences, University of Helsinki, Helsinki, FI-00014, Finland 
43 Nutrition and Dietetics,  Health Science and Education, Harokopio University, Athens, 
17671, Greece 
44 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 
171 77, Sweden 
45 Folkhälsan Research Centre, Helsingfors, FI-00014, Finland 
46 Institute for Computing and Information Sciences, Radboud University Nijmegen, 
Nijmegen, 6525 EC, The Netherlands 
47 Quantitative Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, 
Australia 
48 Lifespan Psychology, Max Planck Institute for Human Development, Berlin, 14195, 
Germany 
49 Department of Twin Research and Genetic Epidemiology, King's College London, London, 
SE1 7EH, UK 
18 
  
                                                                                                                                                                                    
50 NIHR Biomedical Research Centre, Guy’s and St. Thomas’ Foundation Trust, London, 
SE1 7EH, UK 
51 Department of Epidemiology, University of Groningen, University Medical Center 
Groningen, Groningen, 9700 RB, The Netherlands 
52 Public Health Stream, Hunter Medical Research Institute, New Lambton, NSW 2305, 
Australia 
53 Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2300, Australia 
54 Centre for Integrated Genomic Medical Research, Institute of Population Health, The 
University of Manchester, Manchester, M13 9PT, UK 
55 School of Psychological Sciences, The University of Manchester, Manchester, M13 9PL, 
UK 
56 Department of Health, THL-National Institute for Health and Welfare, Helsinki, FI-00271, 
Finland 
57 Psychiatry, VU University Medical Center & GGZ inGeest, Amsterdam, 1081 HL, The 
Netherlands 
58 Laboratory of Genetics, National Institute on Aging, Baltimore, MD 21224, USA 
59 Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, 
Turku, 20521, Finland 
60 Department of Medical Genetics, University of Lausanne, Lausanne, 1005, Switzerland 
61 Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland 
62 Department Of Health Sciences, University of Milan, Milano, 20142, Italy 
63 Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of 
Essen, Essen, 45147, Germany 
64 Centre for Global Health Research, The Usher Institute for Population Health Sciences and 
Informatics, University of Edinburgh, Edinburgh, EH8 9AG, UK 
19 
  
                                                                                                                                                                                    
65 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 
20892-9780, USA 
66 Icelandic Heart Association, Kopavogur, 201, Iceland 
67 Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland 
68 MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK 
69 School of Oral and Dental Sciences, University of Bristol, Bristol, BS1 2LY, UK 
70 Institute for Community Medicine, University Medicine Greifswald, Greifswald, 17475, 
Germany 
71 Department of Cardiology, University Medical Center Groningen, University of 
Groningen, Groningen, 9700 RB, The Netherlands 
72 Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, 48149, 
Germany 
73 Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women’s 
Hospital, Harvard Medical School, MA 02115, Boston, USA 
74 Partners Center for Personalized Genetic Medicine, Boston, MA 02115, USA 
75 Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL 60612, 
USA 
76 Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 
60612, USA 
77 Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA 
78 Department of Gastroenterology and Hepatology, University of Groningen, University 
Medical Center Groningen, Groningen, 9713 GZ, The Netherlands 
79 Institute of Epidemiology and Preventive Medicine, University of Regensburg, 
Regensburg, D-93053, Germany 
80 Institute of Molecular Genetics, National Research Council of Italy, Pavia, 27100, Italy 
20 
  
                                                                                                                                                                                    
81 Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, 
USA 
82 Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK 
83 Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK 
84 Saïd Business School, University of Oxford, Oxford, OX1 1HP, UK 
85 William Harvey Research Institute, Barts and The London School of Medicine and 
Dentistry,  Queen Mary University of London, London, EC1M 6BQ, UK 
86 Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders 
(PACER-HD),  King Abdulaziz University, Jeddah, 21589, Saudi Arabia 
87 The Berlin Aging Study II; Research Group on Geriatrics, Charité – Universitätsmedizin 
Berlin, Germany, Berlin, 13347, Germany 
88 Institute of Medical and Human Genetics, Charité-Universitätsmedizin, Berlin, Berlin, 
13353, Germany 
89 German Socio- Economic Panel Study, DIW Berlin, Berlin, 10117, Germany 
90 Health Economics Research Centre, Nuffield Department of Population Health, University 
of Oxford, Oxford, OX3 7LF, UK 
91 Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, 
MI 48109, USA 
92 Department of Genetics, Division of Statistical Genomics, Washington University School 
of Medicine, St. Louis, MO 63018, USA 
93 Institute of Human Genetics, University of Bonn, Bonn, 53127, Germany 
94 Department of Genomics, Life and Brain Center, University of Bonn, Bonn, 53127, 
Germany 
95 deCODE Genetics/Amgen Inc., Reykjavik, IS-101, Iceland 
21 
  
                                                                                                                                                                                    
96 Institute of Biomedical and Neural Engineering, School of Science and Engineering, 
Reykjavik University, Reykjavik 101, Iceland 
97 Laboratory of Epidemiology, Demography, National Institute on Aging, National Institutes 
of Health, Bethesda, MD 20892-9205, United States 
98 Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 
63110, USA 
99 Division of Applied Health Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UK 
100 Interfaculty Institute for Genetics and Functional Genomics, University Medicine 
Greifswald, Greifswald, 17475, Germany 
101 Manchester Medical School, The University of Manchester, Manchester, 9PT, UK 
102 Program in Translational NeuroPsychiatric Genomics, Departments of Neurology & 
Psychiatry, Brigham and Women’s Hospital, Boston, MA 02115, USA 
103 Harvard Medical School, Boston, MA 02115, USA 
104 Department of Genes and Environment, Norwegian Institute of Public Health, Oslo, N-
0403, Norway 
105 Department of Genomics of Common Disease, Imperial College London, London, W12 
0NN, UK 
106 Department of Clinical Physiology, Tampere University Hospital, Tampere, 33521, 
Finland 
107 Department of Clinical Physiology, University of Tampere, School of Medicine, Tampere, 
33014, Finland 
108 Public Health, Medical School, University of Split, 21000 Split, Croatia 
109 Institute of Social and Preventive Medicine, Lausanne University Hospital (CHUV), 
Lausanne, 1010, Switzerland 
22 
  
                                                                                                                                                                                    
110 Neuroepidemiology Section, National Institute on Aging, National Institutes of Health, 
Bethesda, MD 20892-9205, USA 
111 Amsterdam Brain and Cognition Center, University of Amsterdam, 1018 XA, Amsterdam, 
The Netherlands 
112 Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 
94305-5797, USA 
113 LifeLines Cohort Study, University of Groningen, University Medical Center Groningen, 
Groningen, 9713 BZ, The Netherlands 
114 Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia 
115 Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of 
Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK 
116 Department of Internal Medicine, Internal Medicine, Lausanne University Hospital 
(CHUV), Lausanne, 1011, Switzerland 
117 Tema BV, 2131 HE Hoofddorp, The Netherlands 
118 Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for 
Environmental Health, Neuherberg, 85764, Germany 
119 Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 
4029, Australia 
120 Institute of Health and Biomedical Innovation, Queensland Institute of Technology, 
Brisbane, QLD 4059, Australia 
121 Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General 
Hospital, Boston, MA 02114, USA 
122 The Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 
Cambridge, MA 02142, USA. 
23 
  
                                                                                                                                                                                    
123 Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, 
Massachusetts General Hospital, Boston, MA 02114, USA 
124 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, 
00014, Finland 
125 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 
126 Medical Genetics, Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, 
Trieste, 34100, Italy 
127 Social Impact, Arlington, VA 22201, USA 
128 Department of Economics, University of Minnesota Twin Cities, Minneapolis, MN 55455, 
USA 
129 Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, 
Evanston, IL 60201-3137, USA 
130 Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, 
IL 60637, USA 
131 Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki 00300, 
Finland 
132 Research Unit for Genetic Epidemiology, Institute of Molecular Biology and 
Biochemistry, Center of Molecular Medicine, General Hospital and Medical University, 
Graz, Graz, 8010, Austria 
133 Information Based Medicine Stream, Hunter Medical Research Institute, New Lambton, 
NSW 2305, Australia 
134 Medical Research Institute, University of Dundee, Dundee, DD1 9SY, UK 
135 Research Unit Hypertension and Cardiovascular Epidemiology, Department of 
Cardiovascular Science, University of Leuven, Leuven, 3000, Belgium 
136 R&D VitaK Group, Maastricht University, Maastricht, 6229 EV, The Netherlands 
24 
  
                                                                                                                                                                                    
137 Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research 
Center for Environmental Health, Neuherberg, 85764, Germany 
138 Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic 
Epidemiology, Ludwig Maximilians-Universität, Munich, 81377, Germany 
139 Department of Geriatrics, Florida State University College of Medicine, Tallahassee, FL 
32306, USA 
140 Department of Health Sciences and Genetics, University of Leicester, Leicester, LE1 7RH, 
UK 
141 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, 3015 GE, The 
Netherlands 
142 Research Center for Group Dynamics, Institute for Social Research, University of 
Michigan, Ann Arbor, MI 48104, USA 
143 Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and 
Experimental Genomics, University of Lübeck, Lübeck, 23562, Germany 
144 Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of 
Medicine, The Imperial College of Science, Technology and Medicine, London SW7 2AZ, 
UK 
145 Department of Health Sciences, Community & Occupational Medicine,  University of 
Groningen, University Medical Center Groningen, Groningen, 9713 AV, The Netherlands 
146 Department of Psychology, Union College, Schenectady, NY 12308, USA 
147 Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, c/o 
Cittadella Universitaria di Monserrato, Monserrato, Cagliari, 9042, Italy 
148 Institute of Biomedical Technologies, Italian National Research Council, Segrate 
(Milano), 20090, Italy 
25 
  
                                                                                                                                                                                    
149 Department of General Practice and Primary Health Care, University of Helsinki, 
Helsinki, 00014, Finland 
150 Departments of Human Genetics and Psychiatry, Donders Centre for Neuroscience, 
Nijmegen, 6500 HB, The Netherlands 
151 Sidra, Experimental Genetics Division, Sidra, Doha 26999, Qatar 
152 Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 
Greifswald, 17475, Germany 
153 Department of Psychiatry and Psychotherapy, HELIOS-Hospital Stralsund, Stralsund, 
18437, Germany 
154 Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, 
Rotterdam, 3062 PA, The Netherlands 
155 Department of Genetics, University Medical Center Groningen, University of Groningen, 
Groningen. 9700 RB,  The Netherlands 
156 Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, 
1105 AZ, The Netherlands 
157 Generation Scotland, Centre for Genomics and Experimental Medicine, Institute of 
Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK 
158 Centre for Population Health Research, School of Health Sciences and Sansom Institute, 
University of South Australia, SA5000, Adelaide, Australia 
159 South Australian Health and Medical Research Institute, Adelaide, SA5000, Australia 
160 Population, Policy and Practice, UCL Institute of Child Health, London, WC1N 1EH, UK 
161 Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment & 
Health, School of Public Health, Imperial College London, London, W2 1PG, UK 
162 Center for Life Course Epidemiology, Faculty of Medicine, University of Oulu, Oulu, FI-
90014 , Finland 
26 
  
                                                                                                                                                                                    
163 Unit of Primary Care, Oulu University Hospital, Oulu, 90029 OYS, Finland 
164 Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland 
165 Fimlab Laboratories, Tampere, 33520, Finland 
166 Department of Clinical Chemistry, University of Tampere, School of Medicine, Tampere, 
33014, Finland 
167 Economics, NYU Shanghai, 200122, Pudong, China 
168 Policy Studies, Queen's University, Kingston, K7L3N6, Canada 
169 Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 
4029, Australia 
170 Institute of Molecular and Cell Biology, University of Tartu, Tartu, 51010, Estonia 
171 Centre for Clinical and Cognitive Neuroscience, Institute Brain Behaviour and Mental 
Health, Salford Royal Hospital, Manchester, M6 8HD, UK 
172 Manchester Institute Collaborative Research in Ageing, University of Manchester, 
Manchester, M13 9PL, UK 
173 Faculty of Medicine, University of Split, Croatia, Split 21000, Croatia 
174 Department of Clinical Genetics, VU Medical Centre, Amsterdam, 1081 HV, The 
Netherlands 
175 Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals, The Capital 
Region, Frederiksberg, 2000, Denmark 
176 Montpellier Business School, Montpellier, 34080, France 
177 Panteia, Zoetermeer, 2715 CA, The Netherlands 
178 Department of Psychiatry, Erasmus Medical Center, Rotterdam, 3015 GE, The 
Netherlands 
179 Department of Child and Adolescent Psychiatry, Erasmus Medical Center, Rotterdam, 
3015 GE, The Netherlands 
27 
  
                                                                                                                                                                                    
180 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, 3015 GE, The 
Netherlands 
181 Department of Sociology, New York University, New York, NY 10012, USA 
182 School of Medicine, New York University, NY 10016, New York, USA 
183 Bioethics Program, Union Graduate College - Icahn School of Medicine at Mount Sinai, 
Schenectady, NY 12308, USA 
184 The University of Queensland Diamantina Institute, The Translational Research Institute, 
Brisbane, QLD 4102, Australia 
185 Department of Economics, Stockholm School of Economics, Stockholm, 113 83, Sweden 
186 Department of Genetics, Harvard Medical School, Boston, MA 02115, USA 
187 Research Institute for Industrial Economics, Stockholm, 10215, Sweden 
188 Department of Economics, Cornell University, Ithaca, NY 14853, USA 
189 Center for Economic and Social Research, University of Southern California, Los 
Angeles, CA 90089-3332, USA 
 
 
